Dr. Timothy Worrall is a U.S. and international patent strategist, and chairs the Polsinelli Biotechnology group. He focuses on developing patent portfolios that can be leveraged defensively to protect a client’s existing innovation, and offensively to protect intellectual property in a broader commercial space.
In the pharmaceutical and biotechnology sectors, Dr. Worrall helps innovators protect and maximize the life cycle of pharmaceuticals and biotechnology products, assays, and devices. His practice centers around developing and procuring national and worldwide patent portfolios that extend the value of developing technology. He works closely with attorneys in the patent litigation practice to develop portfolios capable of withstanding litigation, and with the firm's FDA practice to develop non-patent exclusivity.
In the biosimilar space, Dr. Worrall creates strong and extensive patent portfolios that protect biosimilar innovator compounds. He also develops risk assessment strategies for biosimilar platforms, including analysis of inter partes reexams and pre-litigation strategies. Dr. Worrall’s opinion practice focuses on creating value from intellectual property by developing strategies related to freedom to practice reviews, non-infringement and invalidity analysis, to identify and address threats from third-party patents. In the due diligence context on both the investor and company side, Dr. Worrall assesses the strength and weakness of patent portfolios with an emphasis on providing strategic recommendations to address weakness and increase the portfolio’s value.
In the energy and cleantech sectors, Dr. Worrall develops patent portfolios in an often rapidly evolving commercial environment. He works to develop patent strategies that protect key innovations in fast moving and complex markets, and coordinates with the firm's Energy and Utilities team to assess and facilitate regulatory compliance of technology.
In the materials sector, Dr. Worrall develops materials technologies with a focus on technology development, supply chains, international rights, and associated litigation and licensing strategies.
Dr. Worrall also works with licensing and transactional attorneys to leverage intellectual property assets. In particular, he works with transactional attorneys in out-license and in-license agreements, private equity and venture capital transactions, and mergers and acquisitions. Separately, Dr. Worrall works closely with attorneys in litigation and regulatory practices to leverage and maximize intellectual property assets.
Dr. Worrall holds a Ph.D. in Biophysics and Biophysical Chemistry from the Johns Hopkins University School of Medicine, and a J.D. and Certificate in Intellectual Property from the University of California-Berkeley (Boalt Hall). Prior to attending law school, he was a patent examiner at the United States Patent and Trademark Office.